éå»1ã¶æéã«Vanda Pharmaceuticals Incã«å¯ŸããŠè©äŸ¡ãåºããã¢ããªã¹ã4åã«åºã¥ãããŒã¿ã
仿ãVNDAã¯3ä»¶ã®ãè²·ããã1ä»¶ã®ãäžç«ïŒããŒã«ãïŒãã0ä»¶ã®ã売ããè©äŸ¡ãç²åŸããŸãããçŽè¿1ã¶æã«ãããVNDAã®ã¢ããªã¹ãå¹³åç®æšæ ªäŸ¡ã¯12.188ã§ãã
ã¢ããªã¹ãäºæ³ã«ãããšãFY2026Q2ã«çºè¡šãããEPS -1.038ã«ç¶ããVNDAã®FY2026Q3ã®EPSã¯-0.675ã«éããèŠéãã§ããçºè¡šãããå®çžŸå€ãšäºæ³ãæ¯èŒããŠãåçæ§ã®æšç§»ã確èªããŸãããã
åžå Žäºæ³ã¯ USD -1.04 ã§ããããVanda Pharmaceuticals IncVNDA ã®åååæã®äžæ ªåœããå©ç (EPS) 㯠USD -0.82 ã§ãããæ¬¡ã®ååæã® EPS 㯠USD -0.68 ãšäºæ³ãããŸãã